ADVANTIGEN BIOSCIENCES LLC

AdvantiGen Biosciences was founded to enable medical device development and drug discovery that improves the human condition. We utilize our three core technologies to create effective biological tools. Our first core technology is our suite of optical imaging products, which enable tracking of proteins and cells in vitro and in vivo using the Infrared (IR) spectrum. Our second core technology is a proprietary and patented hybridoma antibody platform which enables us to produce significantly more antigen specific clones, which allows us to rapidly develop important diagnostic and therapeutic antibodies. Our third core technology is a novel monobody technology, in combination with our suite of fluorophores, high value reagents for use either in assays or as human therapeutics.By utilizing these technologies AdvantiGen is able to provide our customer tools and services that meet or exceed their specifications leading to the acceleration of their research and development.